Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Perampanel

Perampanel

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Perampanel

17 trials tracked of Perampanel: 9 in phase 3 or 4 and 2 with published results. The most-cited published study has 82 citations.

17Trials tracked
9Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 3 Phase 3 6 Phase 2 8
  1. Phase 3 A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures Completed · 82 cited
  2. Phase 3 Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures Completed · 59 cited
  3. Phase 4 Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization Completed
  4. Phase 4 Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures Completed
  5. Phase 4 Perampanel in Seizure Patients With Primary Glial Brain Tumors Completed
  6. Phase 3 A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures Completed
Show 11 more trials
  1. Phase 3 Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Completed
  2. Phase 3 Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Completed
  3. Phase 3 An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects Completed
  4. Phase 2 Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy Completed
  5. Phase 2 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures Completed
  6. Phase 2 Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence Completed
  7. Phase 2 Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs Completed
  8. Phase 2 A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents Completed
  9. Phase 2 A Study of Intravenous Perampanel in Japanese Participants With Epilepsy Completed
  10. Phase 2 Effect of Perampanel on Peritumoral Hyperexcitability in HGG Completed
  11. Phase 2 A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.